Medicilon is a professional biopharmaceutical preclinical integrated R&D service CRO, providing comprehensive one-stop new drug R&D services that meet domestic and international filing standards for pharmaceutical companies and research institutions around the world. The company's services cover the entire process of preclinical drug discovery research, including drug discovery, pharmaceutical research and preclinical research. Drug discovery R&D services include protein target validation, structural biology, chemical synthesis, compound activity screening and optimization; pharmaceutical research includes API and formulation process research, quality standard and stability research; preclinical research includes pharmacodynamics, pharmacokinetics, toxicology and safety evaluation studies.

Focusing on the needs of the global pharmaceutical industry for innovation and development, and based on the key aspects of innovative drug discovery and development, we have built a comprehensive technology platform covering drug discovery, pharmacological research and key technologies of preclinical research based on the experience we have gained from serving the domestic and overseas biopharmaceutical industries, and we provide a full range of preclinical research and development services for the global biopharmaceutical industry.